These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 11516412

  • 1. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y.
    Brain Res; 2001 Jun 15; 904(1):67-75. PubMed ID: 11516412
    [Abstract] [Full Text] [Related]

  • 2. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
    Aoi M, Date I, Tomita S, Ohmoto T.
    Neurosci Res; 2000 Apr 15; 36(4):319-25. PubMed ID: 10771110
    [Abstract] [Full Text] [Related]

  • 3. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI, Tien LT, Zhou FC, Hoffer BJ, Wang Y.
    Exp Brain Res; 1998 Apr 15; 119(3):287-96. PubMed ID: 9551829
    [Abstract] [Full Text] [Related]

  • 4. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2000 Nov 15; 166(1):1-15. PubMed ID: 11031079
    [Abstract] [Full Text] [Related]

  • 5. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
    Ding YM, Jaumotte JD, Signore AP, Zigmond MJ.
    J Neurochem; 2004 May 15; 89(3):776-87. PubMed ID: 15086533
    [Abstract] [Full Text] [Related]

  • 6. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.
    J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.
    Grant RJ, Clarke PB.
    Neuroscience; 2002 Feb 15; 115(4):1281-94. PubMed ID: 12453497
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C, Papazoglou A, Just L, Nikkhah G.
    Exp Cell Res; 2010 Mar 10; 316(5):737-46. PubMed ID: 20060824
    [Abstract] [Full Text] [Related]

  • 9. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.
    Hoffman AF, van Horne CG, Eken S, Hoffer BJ, Gerhardt GA.
    Exp Neurol; 1997 Sep 10; 147(1):130-41. PubMed ID: 9294410
    [Abstract] [Full Text] [Related]

  • 10. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C, Kirik D, Devaux B, Moffat B, Phillips HS, Björklund A.
    Eur J Neurosci; 1999 May 10; 11(5):1554-66. PubMed ID: 10215908
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.
    Fox CM, Gash DM, Smoot MK, Cass WA.
    Brain Res; 2001 Mar 30; 896(1-2):56-63. PubMed ID: 11277973
    [Abstract] [Full Text] [Related]

  • 12. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
    Wang Y, Tien LT, Lapchak PA, Hoffer BJ.
    Cell Tissue Res; 1996 Nov 30; 286(2):225-33. PubMed ID: 8854891
    [Abstract] [Full Text] [Related]

  • 13. Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats.
    Bowenkamp KE, Lapchak PA, Hoffer BJ, Miller PJ, Bickford PC.
    Exp Neurol; 1997 May 30; 145(1):104-17. PubMed ID: 9184114
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T.
    Neuroscience; 2014 Jan 31; 258():385-400. PubMed ID: 24291725
    [Abstract] [Full Text] [Related]

  • 16. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May 31; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

  • 17. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.
    Sullivan AM, Opacka-Juffry J, Blunt SB.
    Eur J Neurosci; 1998 Jan 31; 10(1):57-63. PubMed ID: 9753113
    [Abstract] [Full Text] [Related]

  • 18. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM, Ortiz R, Dye S, Campbell RB, Amiji MM, Waszczak BL.
    Neuroscience; 2014 Aug 22; 274():11-23. PubMed ID: 24845869
    [Abstract] [Full Text] [Related]

  • 19. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
    Kearns CM, Gash DM.
    Brain Res; 1995 Feb 20; 672(1-2):104-11. PubMed ID: 7749731
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.